Login

Financial Snapshot

Revenue
TTM
$0.00
Gross Margin
Last 4 Quarters
N/A
Net Income
TTM
-$46.28M
Current Assets
2023 Q1
Current Liabilities
2023 Q1
Current Ratio
2023 Q1
59.04%
Total Assets
2023 Q1
Total Liabilities
2023 Q1
Book Value
2023 Q1
-$6.299M
Cash
2023 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$37.24M

Stock Price

Loading...
Market Cap: $14.00

About 9 METERS BIOPHARMA, INC.

9 Meters Biopharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on unmet needs in gastroenterology. The company is headquartered in Raleigh, North Carolina and currently employs 10 full-time employees. The company went IPO on 2016-07-08. The firm has filed a voluntary petition for relief under provisions of Chapter 7 of Title 11 of the United States Code (the Bankruptcy Code) in the United States Bankruptcy Court for the Eastern District of North Carolina.

Industry: Pharmaceutical Preparations Peers: NRX Pharmaceuticals Inc Eton Pharmaceuticals Inc Enliven Therapeutics Inc Johnson & Johnson Journey Medical Corp OPIANT PHARMACEUTICALS, INC. Medicine Man Technologies, Inc. Mystic Holdings Inc./NV Odonate Therapeutics, Inc.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support